Activity
Mon
Wed
Fri
Sun
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
What is this?
Less
More
6 contributions to Peptide Science
NOOTROPICS
Hello Josh, I wondering what type of nootropic is best for Alzheimer and dementia. A friend of mine is nervous because his whole family had it. And I told him about nootropics. He wants to try them to see if it will help.
0 likes • 21d
There is PE-22-28, Adamax-1032, Adalank, Semax, Selank... Cerebrolysin too.
🧬 Selank – Community Q&A
Welcome to the dedicated discussion thread for Selank. This space is for education, research discussion, and shared learning around Selank’s role in neuropeptide signaling, GABA-related pathways, and immune-adjacent peptide research. 📌 How to Use This Thread Use this chat to: • Ask educational questions about synthetic tuftsin-analogue peptides and CNS signaling • Share research-based observations or literature insights • Discuss how Selank is framed in preclinical models of stress-response and cognitive biology • Explore lifestyle and nervous-system fundamentals that sit alongside any research discussion • Compare Selank conceptually with other peptides studied in neuropeptide and nootropic research contexts (including Semax, when the comparison stays mechanism-first) ⚠️ Rules & Safety Guidelines • Research & education only — no medical advice • Respect privacy and keep discussions professional • Report spam or rule violations to moderators Nothing discussed here is intended for human use. 🧬 Educational Overview Selank is a synthetic heptapeptide analogue of tuftsin, a naturally occurring immune-related fragment. In research settings, interest centers on how this stabilized peptide structure may influence GABAergic tone, monoamine signaling, and gene-expression patterns linked to neurotrophic and inflammatory pathways studied in lab and preclinical models. Mechanism-first framing matters more than trend labels. Unlike hype-driven takes that jump straight to mood or performance outcomes, the useful conversation starts with what the molecule is proposed to do at the signaling level: engage pathways overlapping with endogenous regulatory peptides, sit inside broader CNS and immune-crosstalk hypotheses, and leave room for honest limits on evidence quality. Study designs, models, and endpoints vary widely, so science-first discussion here means separating mechanism hypotheses from marketing claims and staying clear about what is still early-stage or context-dependent.
1 like • Sep 14
I have Adamax 1032 and Adalank on the way. I'm excited to see the differences between these and Semax/Selank.
🧬 Retatrutide – Community Q&A
Welcome to the dedicated discussion thread for Retatrutide. This space is for education, research discussion, and shared learning around Retatrutide’s role in metabolic, weight-loss, and energy-regulation research. 📌 How to Use This Thread Use this chat to: • Ask educational questions about GLP-1, GIP, and glucagon receptor pathways • Share research-based observations or literature insights • Discuss metabolic timelines, appetite signaling, or theoretical stacking concepts • Explore lifestyle factors that may influence metabolic outcomes • Compare Retatrutide to other metabolic peptides or agonists ⚠️ Rules & Safety Guidelines • Research & education only — no medical advice • Respect privacy and keep discussions professional • Report spam or rule violations to moderators Nothing discussed here is intended for human use. 🧬 Educational Overview Retatrutide is a multi-agonist metabolic research peptide studied for its simultaneous activation of GLP-1, GIP, and glucagon receptors. This unique triple-pathway signaling profile makes it of strong interest in research related to fat loss, appetite regulation, insulin sensitivity, and overall metabolic efficiency. Unlike single-pathway GLP-1 agonists, Retatrutide’s broader receptor engagement is theorized to promote greater energy expenditure alongside appetite suppression, supporting sustained metabolic changes rather than short-term effects alone. Ongoing research focuses on its potential role in body recomposition, metabolic flexibility, and long-term weight regulation when paired with appropriate lifestyle and behavioral factors. 💬 Main Community Thread Below Post questions, studies, observations, or insights related to Retatrutide research below. High-quality, science-focused contributions are encouraged.
0 likes • Aug 18
@Leah Hernadez I'll review the contents of your Discord.Thank you for your tip
0 likes • Aug 18
@Leah Hernadez I am FNASkippy...😉
Cerebral lysine
Any one know anything about cerebral lysine? Just something i have been researching for a bit now and am curious of what others research has lead them to?
0 likes • Mar 19
I have learned that Cerebrolysin is manufactured in Austria. It is contained in a glass ampule, not a vial. It is always liquid form, not lyophilized powder. If it is called Cerebrolysin and in powder/vial form, it is actually Cerebroprotien. There is a difference between the biological activity profile. I also learned it is best administered via intravenously, sometimes intramuscular.
0 likes • Jun 19
No problem, anytime
GHK-CU/KPV
Hi! I have a combo vial labeled GHK-Cu blend 50mg with KPV 10 mg and I can’t find clear, practical info about reconstitution, concentration, and dosing.
0 likes • Feb 25
Treat it as a 60mg vial, reconstitute with 6ml bac, 10mg/ml. 2mg daily thats 20 units in the syringe.
1-6 of 6
Doug Morton
1
2 points to level up
@doug-morton-4297
Livin life with total gratitude in my heart, harmony with nature and love in my future. I enjoy what life offers up... simplicity is sweet.

Active 5h ago
Joined Jan 13, 2026
Olympic Peninsula, NW Wash